By the time Derion Blackman collapsed in front of a Dollar General in Kissimmee, Florida, in March, he had been waiting two months to regain access to some of the vital medications he’d been taking since undergoing a heart transplant two years prior. His wife, Sonja Smith, recounted the harrowing scene, her voice thick with grief and outrage: "He was on a nasty, dirty ground in front of a store. He didn’t deserve to die like that." Blackman’s death, according to Smith, was the tragic culmination of a Kafkaesque struggle with the U.S. healthcare system, a system that, in her view, failed her husband at every turn.
The couple’s ordeal began in late 2023 when they learned that the monthly premium for their Federal Employees Health Benefits (FEHB) plan would more than double to $307, coupled with a significant increase in their deductible. Faced with escalating costs, they made the difficult decision to switch Blackman’s primary health coverage to CHAMPVA, a health benefits program for dependents of disabled veterans. CHAMPVA offered a compelling alternative: no monthly premiums and a $3,000 deductible. Smith believed they had meticulously planned for a seamless transition, but the reality proved to be anything but.
H2: A Transplant Patient’s Lifeline Severed by Red Tape
Derion Blackman’s life depended on a daily regimen of antirejection medications, crucial for preventing his body from rejecting his transplanted heart. Patients in his situation can develop severe, life-threatening cardiac complications if they miss even a few doses. Smith recalled that Blackman had only enough medication to last approximately one month into the new plan year. Tragically, he informed her just before his death that he had run out, a fact that haunts her.
"I screamed at CHAMPVA. I screamed at the Trump administration. I screamed at the overall healthcare system in this godforsaken country," Smith stated, her voice cracking. "Everybody played a part in what happened to my husband." The Department of Veterans Affairs declined to comment on Blackman’s specific case.
The couple’s plight, while extreme, highlights a growing crisis in American healthcare. As insurance costs continue to soar nationwide, many individuals and families are forced to seek more affordable options. This often involves navigating a fragmented and complex system where insurers, healthcare providers, and pharmaceutical companies independently negotiate costs. The lack of standardization creates significant bureaucratic hurdles for patients, and switching health plans can ensnare individuals in a labyrinth of red tape, ultimately impeding access to necessary care.
Adding to the strain, Congress did not renew COVID-19 pandemic-era subsidies that had helped lower premiums for plans on the Affordable Care Act (ACA) marketplace. Concurrently, the Trump administration has been implementing policies that could potentially create additional barriers for individuals seeking to access Medicaid, the state-federal health insurance program for low-income Americans and those with disabilities. This confluence of factors suggests that more individuals may face the risk of losing their current health coverage.
Adrianna McIntyre, an assistant professor of health policy at the Harvard T.H. Chan School of Public Health, described the situation starkly: "We’ve basically set up a series of cracks in our healthcare system that we ask people to jump over. But if you don’t jump over those cracks, you can lose coverage, or lose access to your doctor, or lose access to your medications."
H2: The Perils of Plan Transitions
Insurers determine plan prices by negotiating rates with individual clinicians, hospital systems, and drug manufacturers. This process leads to a wide variation in coverage levels. Plans with lower monthly premiums often feature narrower networks of doctors and hospitals and less comprehensive drug coverage.
Sabrina Corlette, a research professor in health policy at Georgetown University, explained the downstream effects: "When patients choose an insurer—or even a new plan with the same insurer—they may lose access to medications or doctors that they have had for years." She elaborated that there are numerous ways "patients could get tripped up. When you switch to a new insurance company, they’re going to apply their rules."
In an effort to mitigate some of these issues, the Trump administration announced a pledge last year in which many insurers voluntarily agreed to reduce some bureaucratic obstacles. This pledge includes honoring existing prior authorizations for 90 days when a patient switches health plans. According to AHIP, the primary trade group for the health insurance industry, insurers are also legally required to provide resources such as plain-language plan descriptions and searchable online clinician directories to aid patients in coordinating their care.
Conner Coles, an AHIP spokesperson, stated, "The goal is to ensure every member understands their benefits and can access the care they need without interruption." However, for many patients, understanding their benefits remains a significant challenge.
H3: A Transplant Recipient’s Ongoing Struggle
Monique Acosta, a 54-year-old heart transplant recipient and cancer survivor, found herself navigating multiple health insurance changes after being laid off from her job at a disability nonprofit in October. Initially, she paid nearly $900 a month to maintain her employer coverage through COBRA. In January, she transitioned to Medicaid.
During these transitions, Acosta reported losing coverage for a crucial post-chemotherapy drug. This led her to change her care team to qualify for lower-cost medications through a local hospital’s charity program. Subsequently, one of her new doctors reduced the frequency of an injection she had been receiving for years. During this period, her red and white blood cell counts plummeted, and she experienced significant difficulties recovering from a heart catheterization procedure.
Eventually, her new physician reinstated the injection frequency to twice a month, noting, "He needed to document it so he could see it himself." Acosta described the ordeal: "I was very, very fatigued, very weak, and it’s unnecessarily so." The ongoing uncertainty has led Acosta to postpone a mammogram until she can gain a clearer understanding of her Medicaid plan or secure employment with more comprehensive benefits. "This is overwhelming," she admitted. "This is a lot."
H2: The Burden of Continuity
Federal regulations, along with those in 43 states and Washington, D.C., include "continuity of care protections." These protections mandate that health plans continue to cover existing doctors and medications when there is a network change, such as when a clinician or hospital a patient relies on is terminated from an insurer’s provider network.
However, Corlette pointed out that these protections do not always address the pitfalls patients encounter when they switch insurers independently, for instance, during open enrollment periods or following significant life events.
Shelli Quenga, an insurance agent in South Carolina, suggests that patients can take proactive steps to maintain their care during plan transitions. Her advice includes advising patients to keep meticulous written records of their medical and drug history for new providers. Quenga also stresses the importance of promptly providing new insurance information to doctors, rather than waiting until an appointment. Furthermore, she recommends that patients request a case manager from their insurer to avoid repeatedly explaining their circumstances to different staff members.
Even with diligent preparation, unforeseen challenges can arise. McIntyre noted that doctors can leave networks, and insurers can alter the terms of their plans. "Nobody has an incentive to make it make sense," she concluded. "This puts a lot of burden on the patient."
H3: CHAMPVA’s Unique Structure and Blackman’s Case
The cost-sharing program Blackman was enrolled in, CHAMPVA, serves approximately one million individuals and operates differently from traditional insurance. According to Caira Benson, a staffer at the Code of Support Foundation, an organization supporting veterans, CHAMPVA does not have provider networks or a third-party appeals process. Instead, the program contributes to a portion of a patient’s medical expenses.
Blackman qualified for CHAMPVA because Smith was declared permanently disabled due to physical and mental injuries sustained during her service in the Air Force. CHAMPVA had previously served as Blackman’s secondary insurance.
One of his essential medications cost approximately $800 per month, a significant portion of his disability income. Smith recalled that in November, she contacted CHAMPVA, which she said confirmed coverage for these critical heart medications. Despite this assurance, they encountered substantial bureaucratic obstacles.
A significant hurdle was that CHAMPVA had Blackman’s previous insurance listed as his primary coverage, even though he had canceled that plan. Resolving this administrative error took six weeks. Subsequently, only some of his medications were dispensed, as the health plan indicated that his provider needed to provide further clarification on his prescriptions.
"Now I’m left here trying to piece together all the things that happened," Smith lamented, her voice filled with a profound sense of loss and regret. "I would have kissed him one more time before he walked out the door," she said through sobs. "I feel so cheated."
KFF Health News South Carolina correspondent Lauren Sausser contributed to this report.
Are you struggling to afford your health insurance? Have you decided to forgo coverage? Click here to contact KFF Health News and share your story.
